Organized by the Clinical Research Institute HUCH and the Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology.
Date: Thursday February 18, 2021
Twitter #HHD2021
|
Time |
Presenter |
Title |
Chair |
|
|
Kimmo Porkka |
Opening words |
|
|
09.00 |
John Gribben |
First-line treatment of CLL |
Kimmo Porkka |
|
09.40 |
Robin Foà |
Curing Ph+ALL |
Kimmo Porkka |
|
10.20 |
|
break |
|
|
10.30 |
Luca Vago |
Mechanisms of relapse after alloHSCT |
Urpu Salmenniemi |
|
11.10 |
Nicolas Kröger |
Relapse prevention strategies after alloHSCT in AML and MDS |
Urpu Salmenniemi |
|
12.00 |
|
break |
|
|
12.30 |
Fabio Ciceri |
Keynote: COVID19 in hematological patients |
Kimmo Porkka |
|
Time |
Presenter |
Title |
Chair |
|
13.00 |
Lars Bullinger |
Lessons from Harmony: case AML |
Kimmo Porkka |
|
13.40 |
Aarno Palotie |
FinnGen – facilitating genomic research and patient care |
Ulla Wartiovaara-Kautto |
|
14.20 |
Merja Heinäniemi |
Utilizing big data in hematology research |
Ulla Wartiovaara-Kautto |
|
|
Ulla Wartiovaara-Kautto |
Closing words |
|